Literature DB >> 16417178

Epidemiology of Campylobacter jejuni and Campylobacter coli infections in the Zenica--Doboj Canton, Bosnia and Herzegovina--a laboratory based surveillance in the 1999-2001 period.

Selma Uzunović-Kamberović1.   

Abstract

Previous studies in the Zenica--Doboj Canton, Bosnia and Herzegovina, indicated some different epidemiological features of Campylobacter infections and high degree of antimicrobial resistance. Therefore, it was important to investigate epidemiology of Campylobacter jejuni and Campylobacter coli infections by demographic features and antimicrobial resistance in the 1999-2001 period. A total number of 40 (75.5%) C. jejuni and 13 (24.5%) C. coli non-repeated clinical isolates were analyzed. More than half of isolates, 30 (56.6%) were from urban dwellers. Campylobacter isolates mainly obtained from children under 6 years of age, 42 (79.2%), resulting in far off highest incidence rate of 41.4/100,000/year in this age group. There was noted high degree of resistance to ciprofloxacin in children less than 6 years of age (14.3%), and extremely high overall erythromycin-resistance rate (30%). Campylobacteriosis in this region is a public health concern not in the term of the number reported cases, but of distinctive epidemiologic features.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16417178

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  2 in total

1.  Prevalence of Thermotolerant Campylobacter spp. in Chicken Meat in Croatia and Multilocus Sequence Typing of a Small Subset of Campylobacter jejuni and Campylobacter coli Isolates.

Authors:  Marina Mikulić; Andrea Humski; Bela Njari; Mario Ostović; Sanja Duvnjak; Željko Cvetnić
Journal:  Food Technol Biotechnol       Date:  2016-12       Impact factor: 3.918

2.  Role of poultry meat in sporadic Campylobacter infections in Bosnia and Herzegovina: laboratory-based study.

Authors:  Selma Uzunović-Kamberović; Tina Zorman; Marc Heyndrickx; Sonja Smole Mozina
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.